SOCS1 regulates a subset of NFκB-target genes through direct chromatin binding and defines macrophage functional phenotypes
Diego R. Coelho,
Flavio R. Palma,
Veronica Paviani,
Katy M. LaFond,
Yunping Huang,
Dongmei Wang,
Brian Wray,
Sridhar Rao,
Feng Yue,
Marcelo G. Bonini,
Benjamin N. Gantner
Affiliations
Diego R. Coelho
Department of Medicine/Division of Endocrinology and Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA; Department of Medicine/Division of Hematology Oncology, Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center of Chicago, Chicago, IL 60611, USA
Flavio R. Palma
Department of Medicine/Division of Hematology Oncology, Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center of Chicago, Chicago, IL 60611, USA
Veronica Paviani
Department of Medicine/Division of Hematology Oncology, Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center of Chicago, Chicago, IL 60611, USA
Katy M. LaFond
Department of Medicine/Division of Endocrinology and Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA
Yunping Huang
Department of Medicine/Division of Hematology Oncology, Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center of Chicago, Chicago, IL 60611, USA
Dongmei Wang
Center for Cancer Genomics, Robert H. Lurie Comprehensive Cancer Center of Chicago and Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
Brian Wray
Quantitative Data Science Core, Northwestern University Feinberg School of Medicine, and the Robert H. Lurie Comprehensive Cancer Center of Chicago, Chicago, IL 60611, USA
Sridhar Rao
Versiti Blood Research Institute and Department of Pediatrics/Division of Hematology, Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI 53226, USA
Feng Yue
Center for Cancer Genomics, Robert H. Lurie Comprehensive Cancer Center of Chicago and Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
Marcelo G. Bonini
Department of Medicine/Division of Hematology Oncology, Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center of Chicago, Chicago, IL 60611, USA; Corresponding author
Benjamin N. Gantner
Department of Medicine/Division of Endocrinology and Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA; Corresponding author
Summary: Suppressor of cytokine signaling-1 (SOCS1) exerts control over inflammation by targeting p65 nuclear factor-κB (NF-κB) for degradation in addition to its canonical role regulating cytokine signaling. We report here that SOCS1 does not operate on all p65 targets equally, instead localizing to a select subset of pro-inflammatory genes. Promoter-specific interactions of SOCS1 and p65 determine the subset of genes activated by NF-κB during systemic inflammation, with profound consequences for cytokine responses, immune cell mobilization, and tissue injury. Nitric oxide synthase-1 (NOS1)-derived nitric oxide (NO) is required and sufficient for the displacement of SOCS1 from chromatin, permitting full inflammatory transcription. Single-cell transcriptomic analysis of NOS1-deficient animals led to detection of a regulatory macrophage subset that exerts potent suppression on inflammatory cytokine responses and tissue remodeling. These results provide the first example of a redox-sensitive, gene-specific mechanism for converting macrophages from regulating inflammation to cells licensed to promote aggressive and potentially injurious inflammation.